Poster: ALL-206 Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country

Mahmoud Hammad,Lobna Shalaby,Iman Sidhom,Nancy Sherief,Ibrahim Abdo,Sonia Soliman,Youssef Madeny,Reem Hassan,Shaimaa Elmeniawy,Nagwa Khamis,Iman Zaki,Tarek Mansour,Mohamed Gamal El-Ansary,Ahmed El-Halfawy,Sherif Abouelnaga,Alaa Elhaddad

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2022）

引用 2|浏览4

暂无评分

摘要

Most pediatric cancer patients with COVID-19 should have good clinical outcomes, except for patients with critical infections. Cancer patients can tolerate chemotherapy, including induction phase, alongside COVID-19 treatment. In severe and critical COVID-19, RDV might have a potential benefit.

查看译文

关键词

ALL,COVID-19,immunocompromised patients,remdesivir,pediatric cancer,SARS-CoV-2

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要